Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cornea | 17 | 2024 | 1316 | 4.760 |
Why?
|
Elasticity Imaging Techniques | 9 | 2024 | 398 | 4.340 |
Why?
|
Elastic Modulus | 17 | 2024 | 208 | 4.320 |
Why?
|
Microscopy, Confocal | 23 | 2017 | 1966 | 3.000 |
Why?
|
Keratoconus | 7 | 2019 | 112 | 2.840 |
Why?
|
Lasers | 15 | 2022 | 951 | 2.700 |
Why?
|
Urinary Bladder Neoplasms | 19 | 2024 | 2176 | 2.560 |
Why?
|
Tomography, Optical Coherence | 21 | 2024 | 2932 | 2.250 |
Why?
|
Spectrum Analysis | 9 | 2019 | 443 | 2.170 |
Why?
|
Microscopy | 9 | 2022 | 901 | 2.010 |
Why?
|
Light | 9 | 2023 | 1365 | 1.710 |
Why?
|
BCG Vaccine | 4 | 2024 | 380 | 1.620 |
Why?
|
Photons | 7 | 2015 | 572 | 1.610 |
Why?
|
Optical Fibers | 6 | 2019 | 129 | 1.500 |
Why?
|
Elasticity | 8 | 2018 | 652 | 1.420 |
Why?
|
Photochemotherapy | 6 | 2023 | 826 | 1.410 |
Why?
|
Optics and Photonics | 9 | 2019 | 305 | 1.370 |
Why?
|
Nanotechnology | 5 | 2015 | 703 | 1.310 |
Why?
|
Lenses | 3 | 2016 | 40 | 1.280 |
Why?
|
Refractometry | 5 | 2016 | 57 | 1.180 |
Why?
|
Myopia | 2 | 2023 | 254 | 1.170 |
Why?
|
Cross-Linking Reagents | 4 | 2019 | 687 | 1.130 |
Why?
|
Microscopy, Fluorescence | 10 | 2017 | 2627 | 1.120 |
Why?
|
Ear Ossicles | 2 | 2020 | 71 | 1.110 |
Why?
|
Microfluidic Analytical Techniques | 4 | 2017 | 788 | 1.070 |
Why?
|
Riboflavin | 2 | 2019 | 108 | 1.050 |
Why?
|
Graphite | 3 | 2023 | 79 | 1.000 |
Why?
|
Quantum Dots | 4 | 2023 | 168 | 0.980 |
Why?
|
Art | 2 | 2015 | 66 | 0.970 |
Why?
|
Administration, Intravesical | 2 | 2024 | 88 | 0.950 |
Why?
|
Lens, Crystalline | 4 | 2016 | 387 | 0.930 |
Why?
|
Sclera | 3 | 2023 | 189 | 0.900 |
Why?
|
Hydrogels | 4 | 2023 | 728 | 0.890 |
Why?
|
Gastropoda | 1 | 2023 | 9 | 0.880 |
Why?
|
Endoscopes | 5 | 2013 | 168 | 0.870 |
Why?
|
Stress, Mechanical | 5 | 2022 | 1668 | 0.860 |
Why?
|
Equipment Design | 21 | 2019 | 3481 | 0.830 |
Why?
|
Hyaluronic Acid | 9 | 2018 | 484 | 0.830 |
Why?
|
Biocompatible Materials | 6 | 2019 | 1682 | 0.800 |
Why?
|
Adjuvants, Immunologic | 4 | 2024 | 995 | 0.790 |
Why?
|
Luminescence | 3 | 2023 | 110 | 0.790 |
Why?
|
Swine | 15 | 2023 | 5988 | 0.790 |
Why?
|
Photosensitizing Agents | 5 | 2023 | 625 | 0.780 |
Why?
|
Rose Bengal | 3 | 2017 | 115 | 0.770 |
Why?
|
Click Chemistry | 4 | 2016 | 100 | 0.750 |
Why?
|
Corneal Topography | 2 | 2019 | 69 | 0.740 |
Why?
|
Green Fluorescent Proteins | 5 | 2014 | 2060 | 0.730 |
Why?
|
Lasers, Solid-State | 3 | 2014 | 183 | 0.730 |
Why?
|
Diagnostic Imaging | 8 | 2023 | 3529 | 0.720 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2024 | 1043 | 0.690 |
Why?
|
Collagen | 4 | 2019 | 2618 | 0.690 |
Why?
|
Animals | 82 | 2023 | 168764 | 0.680 |
Why?
|
Optical Phenomena | 5 | 2018 | 103 | 0.670 |
Why?
|
Vibration | 4 | 2020 | 334 | 0.660 |
Why?
|
Diagnostic Techniques, Ophthalmological | 4 | 2019 | 252 | 0.660 |
Why?
|
Absorbable Implants | 2 | 2019 | 333 | 0.660 |
Why?
|
Corneal Edema | 1 | 2020 | 45 | 0.650 |
Why?
|
Microfluidics | 2 | 2022 | 651 | 0.640 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2016 | 950 | 0.640 |
Why?
|
Fluorescent Dyes | 6 | 2023 | 1930 | 0.630 |
Why?
|
Biological Science Disciplines | 2 | 2015 | 58 | 0.610 |
Why?
|
Miniaturization | 4 | 2013 | 150 | 0.600 |
Why?
|
Biosensing Techniques | 2 | 2014 | 642 | 0.600 |
Why?
|
Porphyrins | 3 | 2015 | 351 | 0.590 |
Why?
|
Urokinase-Type Plasminogen Activator | 2 | 2016 | 323 | 0.590 |
Why?
|
Cell Movement | 9 | 2017 | 5194 | 0.580 |
Why?
|
Fuchs' Endothelial Dystrophy | 1 | 2020 | 103 | 0.580 |
Why?
|
Lighting | 2 | 2018 | 211 | 0.570 |
Why?
|
Polymers | 5 | 2019 | 1621 | 0.560 |
Why?
|
Cell Tracking | 2 | 2016 | 139 | 0.560 |
Why?
|
Image Enhancement | 9 | 2016 | 2858 | 0.560 |
Why?
|
Mechanical Phenomena | 4 | 2016 | 141 | 0.560 |
Why?
|
Ultraviolet Rays | 3 | 2019 | 1102 | 0.560 |
Why?
|
Singlet Oxygen | 1 | 2017 | 58 | 0.550 |
Why?
|
Body Water | 1 | 2018 | 338 | 0.550 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1857 | 0.540 |
Why?
|
Biotechnology | 2 | 2017 | 284 | 0.530 |
Why?
|
Vocal Cords | 2 | 2011 | 520 | 0.520 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2016 | 498 | 0.520 |
Why?
|
Electrolytes | 1 | 2017 | 280 | 0.510 |
Why?
|
Cell Adhesion | 5 | 2016 | 3089 | 0.510 |
Why?
|
Orbit | 1 | 2019 | 456 | 0.510 |
Why?
|
Luciferases | 2 | 2017 | 713 | 0.510 |
Why?
|
Carbocyanines | 1 | 2016 | 177 | 0.500 |
Why?
|
Photochemistry | 1 | 2016 | 238 | 0.490 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2015 | 46 | 0.490 |
Why?
|
Adhesives | 1 | 2015 | 66 | 0.490 |
Why?
|
Tears | 1 | 2017 | 254 | 0.480 |
Why?
|
Time-Lapse Imaging | 2 | 2013 | 195 | 0.480 |
Why?
|
Taste Perception | 1 | 2015 | 38 | 0.470 |
Why?
|
Energy Transfer | 1 | 2014 | 108 | 0.470 |
Why?
|
Water | 2 | 2018 | 1417 | 0.460 |
Why?
|
Imaging, Three-Dimensional | 10 | 2015 | 4034 | 0.460 |
Why?
|
Calgranulin A | 1 | 2014 | 80 | 0.450 |
Why?
|
Calgranulin B | 1 | 2014 | 87 | 0.450 |
Why?
|
Regeneration | 2 | 2013 | 1517 | 0.450 |
Why?
|
Corneal Stroma | 2 | 2013 | 166 | 0.450 |
Why?
|
Colonoscopes | 1 | 2013 | 17 | 0.450 |
Why?
|
Glutathione | 1 | 2016 | 588 | 0.450 |
Why?
|
Licensure | 1 | 2015 | 128 | 0.440 |
Why?
|
Mice | 46 | 2023 | 81819 | 0.440 |
Why?
|
Taste | 1 | 2015 | 190 | 0.440 |
Why?
|
Equipment Failure Analysis | 10 | 2016 | 834 | 0.430 |
Why?
|
Neoplasm Invasiveness | 9 | 2024 | 3602 | 0.420 |
Why?
|
Contact Lenses | 1 | 2014 | 137 | 0.420 |
Why?
|
Mice, Inbred BALB C | 13 | 2018 | 6220 | 0.420 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2015 | 347 | 0.420 |
Why?
|
Biopolymers | 1 | 2013 | 181 | 0.410 |
Why?
|
RNA | 1 | 2022 | 2717 | 0.410 |
Why?
|
Nanoparticles | 9 | 2017 | 1964 | 0.400 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 3 | 2016 | 265 | 0.400 |
Why?
|
Copper | 1 | 2015 | 367 | 0.400 |
Why?
|
Academies and Institutes | 1 | 2015 | 326 | 0.400 |
Why?
|
Colon | 3 | 2015 | 1795 | 0.390 |
Why?
|
Luminescent Proteins | 1 | 2014 | 839 | 0.390 |
Why?
|
Melanoma, Experimental | 5 | 2016 | 558 | 0.380 |
Why?
|
Nucleic Acids | 1 | 2014 | 193 | 0.380 |
Why?
|
Private Sector | 1 | 2015 | 396 | 0.380 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2023 | 1758 | 0.380 |
Why?
|
Prostatic Hyperplasia | 2 | 2015 | 515 | 0.370 |
Why?
|
Tympanic Membrane | 1 | 2013 | 233 | 0.370 |
Why?
|
Nanostructures | 4 | 2018 | 548 | 0.370 |
Why?
|
Single-Cell Analysis | 3 | 2023 | 2535 | 0.360 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2024 | 9373 | 0.360 |
Why?
|
Oscillometry | 1 | 2011 | 151 | 0.360 |
Why?
|
Point-of-Care Systems | 2 | 2017 | 1217 | 0.360 |
Why?
|
Monocytes | 3 | 2017 | 2595 | 0.360 |
Why?
|
Extracellular Matrix | 2 | 2015 | 1727 | 0.350 |
Why?
|
Semiconductors | 5 | 2018 | 99 | 0.350 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2015 | 426 | 0.350 |
Why?
|
Cytoskeleton | 1 | 2015 | 1178 | 0.350 |
Why?
|
Phototherapy | 5 | 2023 | 370 | 0.340 |
Why?
|
Genetic Engineering | 2 | 2017 | 933 | 0.340 |
Why?
|
Neoplasms | 6 | 2023 | 22340 | 0.340 |
Why?
|
Colonic Neoplasms | 4 | 2015 | 2531 | 0.340 |
Why?
|
Humans | 88 | 2024 | 765968 | 0.340 |
Why?
|
Early Diagnosis | 1 | 2014 | 1187 | 0.320 |
Why?
|
Disease Models, Animal | 10 | 2018 | 18293 | 0.320 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1229 | 0.320 |
Why?
|
Lead | 1 | 2015 | 879 | 0.320 |
Why?
|
Biological Clocks | 1 | 2011 | 320 | 0.310 |
Why?
|
Cell Line, Tumor | 16 | 2023 | 17075 | 0.310 |
Why?
|
Polyethylene Glycols | 5 | 2023 | 1188 | 0.310 |
Why?
|
Disease Progression | 12 | 2024 | 13632 | 0.310 |
Why?
|
Spectrophotometry | 1 | 2008 | 288 | 0.300 |
Why?
|
Gene Expression Profiling | 9 | 2023 | 9525 | 0.300 |
Why?
|
Eye | 1 | 2012 | 710 | 0.290 |
Why?
|
Hypothalamus | 1 | 2013 | 993 | 0.290 |
Why?
|
Garlic | 2 | 2018 | 29 | 0.290 |
Why?
|
Intestinal Mucosa | 3 | 2013 | 3046 | 0.290 |
Why?
|
Medicine | 1 | 2016 | 942 | 0.280 |
Why?
|
Fluorescence | 4 | 2014 | 753 | 0.280 |
Why?
|
Chinchilla | 2 | 2020 | 77 | 0.280 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2014 | 1242 | 0.270 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 3 | 2022 | 548 | 0.270 |
Why?
|
Photochemical Processes | 2 | 2017 | 84 | 0.270 |
Why?
|
Erythrocytes | 1 | 2016 | 2395 | 0.270 |
Why?
|
Neovascularization, Pathologic | 3 | 2022 | 2631 | 0.270 |
Why?
|
Laser Therapy | 1 | 2013 | 1108 | 0.270 |
Why?
|
Dermis | 2 | 2022 | 204 | 0.270 |
Why?
|
Drug Carriers | 5 | 2017 | 700 | 0.270 |
Why?
|
Trachea | 1 | 2012 | 1085 | 0.260 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2010 | 888 | 0.260 |
Why?
|
Fibrinolytic Agents | 1 | 2015 | 2080 | 0.250 |
Why?
|
NIH 3T3 Cells | 3 | 2017 | 651 | 0.250 |
Why?
|
RNA, Messenger | 4 | 2014 | 12768 | 0.250 |
Why?
|
Drug Delivery Systems | 4 | 2023 | 2207 | 0.250 |
Why?
|
Disulfides | 2 | 2018 | 462 | 0.250 |
Why?
|
Colorimetry | 2 | 2017 | 148 | 0.240 |
Why?
|
Urolithiasis | 2 | 2019 | 123 | 0.240 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5444 | 0.240 |
Why?
|
Descemet Stripping Endothelial Keratoplasty | 2 | 2020 | 110 | 0.240 |
Why?
|
Aging | 2 | 2016 | 8731 | 0.240 |
Why?
|
Heart | 2 | 2016 | 4414 | 0.240 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2011 | 3356 | 0.240 |
Why?
|
Glaucoma | 1 | 2014 | 1194 | 0.240 |
Why?
|
Jurkat Cells | 2 | 2016 | 737 | 0.230 |
Why?
|
Mice, Inbred C57BL | 15 | 2017 | 22332 | 0.230 |
Why?
|
Adenoma | 1 | 2015 | 2152 | 0.230 |
Why?
|
Interleukin-5 | 2 | 2017 | 268 | 0.230 |
Why?
|
Endoscopy | 3 | 2013 | 1841 | 0.220 |
Why?
|
Plant Extracts | 2 | 2018 | 496 | 0.220 |
Why?
|
Scattering, Radiation | 3 | 2012 | 482 | 0.220 |
Why?
|
Flow Cytometry | 7 | 2023 | 5881 | 0.220 |
Why?
|
Pilot Projects | 3 | 2023 | 8733 | 0.220 |
Why?
|
Intraocular Pressure | 2 | 2023 | 1304 | 0.220 |
Why?
|
Tissue Distribution | 4 | 2023 | 2266 | 0.220 |
Why?
|
Cattle | 4 | 2014 | 3801 | 0.210 |
Why?
|
Models, Theoretical | 6 | 2019 | 3564 | 0.210 |
Why?
|
Materials Testing | 3 | 2015 | 868 | 0.210 |
Why?
|
Vision Tests | 1 | 2023 | 160 | 0.210 |
Why?
|
Heart Transplantation | 1 | 2016 | 3310 | 0.200 |
Why?
|
Euphausiacea | 1 | 2022 | 2 | 0.200 |
Why?
|
Escherichia coli | 2 | 2012 | 4214 | 0.200 |
Why?
|
Mice, Nude | 7 | 2018 | 3618 | 0.200 |
Why?
|
Phytotherapy | 2 | 2018 | 298 | 0.200 |
Why?
|
Spectrometry, Fluorescence | 3 | 2016 | 697 | 0.200 |
Why?
|
Ultrasonics | 1 | 2023 | 209 | 0.200 |
Why?
|
Prognosis | 11 | 2024 | 29922 | 0.200 |
Why?
|
Refraction, Ocular | 1 | 2023 | 188 | 0.200 |
Why?
|
Acoustics | 1 | 2023 | 235 | 0.190 |
Why?
|
Computer Simulation | 2 | 2014 | 6255 | 0.190 |
Why?
|
Paraffin Embedding | 1 | 2022 | 301 | 0.190 |
Why?
|
Subcutaneous Tissue | 1 | 2022 | 130 | 0.190 |
Why?
|
Fiber Optic Technology | 4 | 2009 | 284 | 0.180 |
Why?
|
Formaldehyde | 1 | 2022 | 352 | 0.180 |
Why?
|
Macrophages | 1 | 2016 | 5772 | 0.180 |
Why?
|
Motion | 2 | 2016 | 781 | 0.180 |
Why?
|
Epithelial Cells | 1 | 2012 | 3681 | 0.170 |
Why?
|
Male | 34 | 2024 | 363698 | 0.170 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 8 | 2014 | 4562 | 0.170 |
Why?
|
Adult | 19 | 2024 | 223044 | 0.170 |
Why?
|
Silicone Elastomers | 1 | 2019 | 78 | 0.160 |
Why?
|
Antigens, Ly | 2 | 2017 | 296 | 0.160 |
Why?
|
Middle Aged | 21 | 2024 | 223009 | 0.160 |
Why?
|
Pancreatic Elastase | 2 | 2023 | 124 | 0.160 |
Why?
|
Azides | 2 | 2016 | 120 | 0.160 |
Why?
|
Telemedicine | 1 | 2017 | 3105 | 0.160 |
Why?
|
Biomedical Research | 1 | 2015 | 3458 | 0.160 |
Why?
|
Epidermis | 1 | 2022 | 538 | 0.160 |
Why?
|
Female | 33 | 2024 | 396112 | 0.160 |
Why?
|
Reproducibility of Results | 12 | 2017 | 20124 | 0.160 |
Why?
|
Molybdenum | 1 | 2018 | 45 | 0.160 |
Why?
|
Chlorophyllides | 2 | 2015 | 54 | 0.150 |
Why?
|
Viscosity | 1 | 2019 | 334 | 0.150 |
Why?
|
Silver | 1 | 2019 | 120 | 0.150 |
Why?
|
Colorectal Neoplasms | 2 | 2017 | 6942 | 0.150 |
Why?
|
Anisotropy | 1 | 2022 | 1282 | 0.150 |
Why?
|
Sound | 1 | 2020 | 257 | 0.150 |
Why?
|
Cell Separation | 2 | 2022 | 1718 | 0.150 |
Why?
|
Sheep, Domestic | 1 | 2017 | 52 | 0.150 |
Why?
|
Rabbits | 3 | 2019 | 4734 | 0.140 |
Why?
|
Renilla | 1 | 2017 | 6 | 0.140 |
Why?
|
Blood Chemical Analysis | 1 | 2019 | 433 | 0.140 |
Why?
|
Cross Protection | 1 | 2017 | 25 | 0.140 |
Why?
|
Nanofibers | 1 | 2017 | 67 | 0.140 |
Why?
|
Polystyrenes | 1 | 2017 | 102 | 0.140 |
Why?
|
Prostatic Neoplasms | 3 | 2015 | 11083 | 0.140 |
Why?
|
Centromere | 1 | 2018 | 213 | 0.140 |
Why?
|
Interferometry | 2 | 2009 | 101 | 0.140 |
Why?
|
Coated Materials, Biocompatible | 1 | 2019 | 314 | 0.140 |
Why?
|
Crops, Agricultural | 1 | 2017 | 39 | 0.140 |
Why?
|
Paper | 1 | 2017 | 80 | 0.140 |
Why?
|
Cerebral Cortex | 1 | 2013 | 5767 | 0.140 |
Why?
|
Blood | 1 | 2019 | 597 | 0.130 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2016 | 44 | 0.130 |
Why?
|
Cyclooctanes | 1 | 2016 | 37 | 0.130 |
Why?
|
Neoplasm Metastasis | 3 | 2016 | 4893 | 0.130 |
Why?
|
Accommodation, Ocular | 1 | 2016 | 47 | 0.130 |
Why?
|
Skin | 5 | 2017 | 4489 | 0.130 |
Why?
|
Young Adult | 9 | 2024 | 59889 | 0.130 |
Why?
|
Needles | 1 | 2019 | 460 | 0.130 |
Why?
|
Nanotubes | 1 | 2016 | 83 | 0.130 |
Why?
|
Case-Control Studies | 8 | 2019 | 22223 | 0.130 |
Why?
|
Fingers | 3 | 2009 | 509 | 0.130 |
Why?
|
Insulin-Secreting Cells | 1 | 2023 | 898 | 0.130 |
Why?
|
Administration, Cutaneous | 5 | 2016 | 715 | 0.130 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 2 | 2014 | 390 | 0.120 |
Why?
|
Muscular Dystrophy, Animal | 1 | 2015 | 89 | 0.120 |
Why?
|
Microtechnology | 1 | 2015 | 64 | 0.120 |
Why?
|
Brain | 5 | 2019 | 27171 | 0.120 |
Why?
|
Retina | 3 | 2017 | 2657 | 0.120 |
Why?
|
Software | 3 | 2017 | 4462 | 0.120 |
Why?
|
Hexuronic Acids | 1 | 2015 | 144 | 0.120 |
Why?
|
Glucuronic Acid | 1 | 2015 | 148 | 0.120 |
Why?
|
Taste Buds | 1 | 2015 | 23 | 0.120 |
Why?
|
Osmotic Pressure | 1 | 2015 | 136 | 0.120 |
Why?
|
Sulfonic Acids | 1 | 2015 | 103 | 0.120 |
Why?
|
Aged | 17 | 2024 | 171117 | 0.120 |
Why?
|
ROC Curve | 3 | 2019 | 3620 | 0.120 |
Why?
|
Metal Nanoparticles | 2 | 2018 | 403 | 0.120 |
Why?
|
Disease-Free Survival | 3 | 2021 | 6832 | 0.120 |
Why?
|
Selenium-Binding Proteins | 1 | 2014 | 18 | 0.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2017 | 8611 | 0.120 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2015 | 204 | 0.120 |
Why?
|
Blood Circulation | 1 | 2015 | 248 | 0.120 |
Why?
|
Hair | 1 | 2018 | 508 | 0.120 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2017 | 393 | 0.120 |
Why?
|
Hypolipoproteinemias | 1 | 2014 | 2 | 0.120 |
Why?
|
Orthomyxoviridae Infections | 1 | 2017 | 254 | 0.120 |
Why?
|
Algorithms | 5 | 2017 | 14071 | 0.120 |
Why?
|
Cisplatin | 2 | 2018 | 1658 | 0.120 |
Why?
|
Nanocapsules | 1 | 2015 | 92 | 0.110 |
Why?
|
Microspheres | 1 | 2017 | 773 | 0.110 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2015 | 182 | 0.110 |
Why?
|
Receptors, Chemokine | 1 | 2017 | 651 | 0.110 |
Why?
|
Flavin Mononucleotide | 1 | 2013 | 8 | 0.110 |
Why?
|
Neutrophils | 3 | 2017 | 3776 | 0.110 |
Why?
|
Alopecia | 1 | 2018 | 414 | 0.110 |
Why?
|
Lung Neoplasms | 2 | 2015 | 13451 | 0.110 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2017 | 707 | 0.110 |
Why?
|
Alginates | 1 | 2015 | 247 | 0.110 |
Why?
|
Crystallization | 1 | 2014 | 521 | 0.110 |
Why?
|
Molecular Conformation | 1 | 2015 | 541 | 0.110 |
Why?
|
Muscle Neoplasms | 2 | 2014 | 130 | 0.110 |
Why?
|
Bacteria | 1 | 2024 | 2209 | 0.110 |
Why?
|
Microscopy, Atomic Force | 4 | 2017 | 250 | 0.110 |
Why?
|
Cell Size | 1 | 2015 | 625 | 0.110 |
Why?
|
Influenza A virus | 1 | 2017 | 453 | 0.110 |
Why?
|
Phantoms, Imaging | 1 | 2022 | 2475 | 0.110 |
Why?
|
Aged, 80 and over | 9 | 2021 | 59489 | 0.110 |
Why?
|
Ceramics | 1 | 2014 | 113 | 0.110 |
Why?
|
Electronics | 1 | 2014 | 314 | 0.100 |
Why?
|
Cell Survival | 4 | 2015 | 5747 | 0.100 |
Why?
|
Colitis | 2 | 2013 | 1239 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2022 | 3513 | 0.100 |
Why?
|
Citrobacter rodentium | 1 | 2013 | 64 | 0.100 |
Why?
|
Sensitivity and Specificity | 8 | 2016 | 14652 | 0.100 |
Why?
|
Feasibility Studies | 3 | 2015 | 5302 | 0.100 |
Why?
|
Leukocyte Rolling | 1 | 2013 | 69 | 0.100 |
Why?
|
Latex | 1 | 2012 | 49 | 0.100 |
Why?
|
Lysine-tRNA Ligase | 1 | 2012 | 5 | 0.100 |
Why?
|
Secondary Prevention | 1 | 2019 | 1472 | 0.100 |
Why?
|
Fibrin | 1 | 2015 | 513 | 0.100 |
Why?
|
Receptors, Laminin | 1 | 2012 | 26 | 0.100 |
Why?
|
Receptors, CXCR4 | 1 | 2017 | 728 | 0.100 |
Why?
|
Potassium | 1 | 2017 | 1311 | 0.100 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2014 | 173 | 0.100 |
Why?
|
Temperature | 1 | 2019 | 2226 | 0.100 |
Why?
|
Carbon | 2 | 2015 | 677 | 0.100 |
Why?
|
Photography | 1 | 2015 | 533 | 0.100 |
Why?
|
Glycerol | 1 | 2013 | 274 | 0.100 |
Why?
|
HeLa Cells | 2 | 2016 | 3067 | 0.100 |
Why?
|
Sulfur Dioxide | 1 | 2012 | 178 | 0.100 |
Why?
|
Dry Eye Syndromes | 1 | 2017 | 384 | 0.100 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2014 | 416 | 0.100 |
Why?
|
Elastin | 1 | 2013 | 299 | 0.100 |
Why?
|
Heart Failure | 1 | 2016 | 11840 | 0.100 |
Why?
|
Peptides | 2 | 2015 | 4331 | 0.100 |
Why?
|
Coloring Agents | 1 | 2014 | 564 | 0.100 |
Why?
|
Cell Line | 6 | 2016 | 15543 | 0.100 |
Why?
|
Pinus | 1 | 2011 | 16 | 0.100 |
Why?
|
Ocular Physiological Phenomena | 1 | 2012 | 67 | 0.100 |
Why?
|
Oximetry | 1 | 2015 | 459 | 0.100 |
Why?
|
Oxides | 1 | 2014 | 402 | 0.100 |
Why?
|
Cell Count | 2 | 2013 | 1823 | 0.100 |
Why?
|
Histocytochemistry | 1 | 2013 | 696 | 0.100 |
Why?
|
Immobilization | 1 | 2013 | 225 | 0.100 |
Why?
|
Myocardial Infarction | 1 | 2013 | 11499 | 0.100 |
Why?
|
Ovarian Neoplasms | 3 | 2016 | 4900 | 0.100 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2017 | 952 | 0.100 |
Why?
|
Optical Devices | 1 | 2011 | 34 | 0.100 |
Why?
|
Cystectomy | 1 | 2016 | 604 | 0.100 |
Why?
|
Polyesters | 1 | 2013 | 372 | 0.100 |
Why?
|
Suction | 1 | 2013 | 265 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2011 | 91 | 0.090 |
Why?
|
Tongue | 1 | 2015 | 405 | 0.090 |
Why?
|
Mice, Transgenic | 3 | 2013 | 9550 | 0.090 |
Why?
|
Apoptosis | 7 | 2018 | 9514 | 0.090 |
Why?
|
Lasers, Dye | 1 | 2011 | 28 | 0.090 |
Why?
|
Angiogenesis Inhibitors | 2 | 2022 | 2056 | 0.090 |
Why?
|
Sodium | 1 | 2017 | 1591 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2017 | 5337 | 0.090 |
Why?
|
Mucous Membrane | 1 | 2015 | 657 | 0.090 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2011 | 58 | 0.090 |
Why?
|
Immunoenzyme Techniques | 1 | 2014 | 1701 | 0.090 |
Why?
|
Ear Diseases | 1 | 2013 | 179 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2015 | 561 | 0.090 |
Why?
|
Video Recording | 1 | 2016 | 969 | 0.090 |
Why?
|
Propylene Glycols | 1 | 2011 | 91 | 0.090 |
Why?
|
Enterobacteriaceae Infections | 1 | 2013 | 189 | 0.090 |
Why?
|
Microscopy, Polarization | 2 | 2008 | 88 | 0.090 |
Why?
|
Interferon-alpha | 1 | 2015 | 910 | 0.090 |
Why?
|
Hypertriglyceridemia | 1 | 2014 | 290 | 0.090 |
Why?
|
Models, Biological | 3 | 2024 | 9443 | 0.090 |
Why?
|
Skin Neoplasms | 4 | 2016 | 5849 | 0.090 |
Why?
|
Silicon | 1 | 2011 | 141 | 0.090 |
Why?
|
Macrophage-1 Antigen | 1 | 2011 | 283 | 0.090 |
Why?
|
Microscopy, Video | 2 | 2010 | 241 | 0.090 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2012 | 196 | 0.090 |
Why?
|
Laminin | 1 | 2012 | 404 | 0.090 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2016 | 750 | 0.090 |
Why?
|
Oenothera biennis | 1 | 2010 | 3 | 0.090 |
Why?
|
RNA, Bacterial | 1 | 2012 | 392 | 0.090 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2009 | 1456 | 0.090 |
Why?
|
Corneal Transplantation | 1 | 2014 | 315 | 0.090 |
Why?
|
Molecular Structure | 1 | 2014 | 1885 | 0.090 |
Why?
|
Models, Animal | 2 | 2015 | 2120 | 0.090 |
Why?
|
Whole Body Imaging | 1 | 2012 | 281 | 0.090 |
Why?
|
Antigens | 1 | 2015 | 1438 | 0.090 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39193 | 0.080 |
Why?
|
Microtubule-Associated Proteins | 1 | 2015 | 1066 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 938 | 0.080 |
Why?
|
Neovascularization, Physiologic | 1 | 2017 | 1375 | 0.080 |
Why?
|
Retinal Vessels | 2 | 2006 | 863 | 0.080 |
Why?
|
Kidney Calculi | 1 | 2014 | 457 | 0.080 |
Why?
|
Survival Rate | 5 | 2014 | 12795 | 0.080 |
Why?
|
Influenza Vaccines | 1 | 2017 | 778 | 0.080 |
Why?
|
Molecular Imaging | 1 | 2016 | 822 | 0.080 |
Why?
|
Tail | 1 | 2010 | 91 | 0.080 |
Why?
|
Axons | 1 | 2017 | 1682 | 0.080 |
Why?
|
Lipoproteins, HDL | 1 | 2014 | 674 | 0.080 |
Why?
|
Rhodamines | 1 | 2010 | 178 | 0.080 |
Why?
|
Niacinamide | 1 | 2011 | 419 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1490 | 0.080 |
Why?
|
Sphingosine | 1 | 2011 | 306 | 0.080 |
Why?
|
Micelles | 1 | 2010 | 188 | 0.080 |
Why?
|
Carcinoma, Papillary | 1 | 2014 | 788 | 0.080 |
Why?
|
Mice, Knockout | 5 | 2017 | 14448 | 0.080 |
Why?
|
Plant Oils | 1 | 2010 | 199 | 0.080 |
Why?
|
Rubber | 1 | 2008 | 32 | 0.080 |
Why?
|
Candidiasis | 1 | 2011 | 371 | 0.080 |
Why?
|
Kinetics | 1 | 2016 | 6274 | 0.080 |
Why?
|
Carcinoma in Situ | 2 | 2011 | 779 | 0.080 |
Why?
|
Paclitaxel | 1 | 2016 | 1728 | 0.080 |
Why?
|
Interleukin-2 | 1 | 2015 | 1896 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 2 | 2014 | 3181 | 0.080 |
Why?
|
Phonation | 1 | 2010 | 221 | 0.080 |
Why?
|
Acoustic Stimulation | 1 | 2013 | 1255 | 0.080 |
Why?
|
Candida albicans | 1 | 2011 | 377 | 0.080 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2011 | 657 | 0.080 |
Why?
|
Quantum Theory | 1 | 2008 | 69 | 0.080 |
Why?
|
Genes, Reporter | 1 | 2012 | 1524 | 0.080 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1748 | 0.080 |
Why?
|
Muscle, Smooth | 1 | 2012 | 931 | 0.080 |
Why?
|
Lactic Acid | 1 | 2013 | 1137 | 0.080 |
Why?
|
Lectins, C-Type | 1 | 2011 | 592 | 0.080 |
Why?
|
Prostheses and Implants | 1 | 2015 | 1273 | 0.070 |
Why?
|
Nephrectomy | 1 | 2013 | 927 | 0.070 |
Why?
|
Hepacivirus | 1 | 2015 | 1343 | 0.070 |
Why?
|
Solutions | 1 | 2008 | 403 | 0.070 |
Why?
|
Genes, Neoplasm | 1 | 2010 | 370 | 0.070 |
Why?
|
Melanins | 1 | 2010 | 293 | 0.070 |
Why?
|
Skin Pigmentation | 1 | 2010 | 279 | 0.070 |
Why?
|
Microcirculation | 1 | 2013 | 1280 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12509 | 0.070 |
Why?
|
Artifacts | 1 | 2016 | 1893 | 0.070 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2012 | 488 | 0.070 |
Why?
|
Silicones | 1 | 2008 | 228 | 0.070 |
Why?
|
Lung Injury | 1 | 2012 | 430 | 0.070 |
Why?
|
Myocardial Contraction | 1 | 2013 | 1515 | 0.070 |
Why?
|
Models, Molecular | 2 | 2015 | 5379 | 0.070 |
Why?
|
Tumor Cells, Cultured | 4 | 2017 | 6113 | 0.070 |
Why?
|
Interleukins | 1 | 2012 | 791 | 0.070 |
Why?
|
Graft Rejection | 2 | 2011 | 4499 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12056 | 0.070 |
Why?
|
RNA Splicing | 1 | 2012 | 903 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2016 | 2324 | 0.070 |
Why?
|
Aorta, Thoracic | 1 | 2013 | 1103 | 0.070 |
Why?
|
Human Growth Hormone | 1 | 2012 | 638 | 0.070 |
Why?
|
Endocytosis | 3 | 2018 | 951 | 0.070 |
Why?
|
Kidney Neoplasms | 2 | 2014 | 4274 | 0.070 |
Why?
|
Neoplasm Staging | 4 | 2014 | 11206 | 0.070 |
Why?
|
Tooth | 1 | 2008 | 210 | 0.070 |
Why?
|
Antigen-Presenting Cells | 1 | 2010 | 962 | 0.070 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 1761 | 0.070 |
Why?
|
Prostate | 1 | 2015 | 1755 | 0.070 |
Why?
|
Immunity, Cellular | 1 | 2013 | 1555 | 0.070 |
Why?
|
Promoter Regions, Genetic | 3 | 2012 | 5786 | 0.070 |
Why?
|
Th17 Cells | 1 | 2013 | 786 | 0.070 |
Why?
|
Molecular Targeted Therapy | 2 | 2018 | 2822 | 0.070 |
Why?
|
Diabetes Complications | 1 | 2013 | 1316 | 0.070 |
Why?
|
Amplifiers, Electronic | 1 | 2006 | 16 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2014 | 8923 | 0.070 |
Why?
|
Immunity, Mucosal | 1 | 2010 | 498 | 0.070 |
Why?
|
Movement | 1 | 2013 | 1462 | 0.070 |
Why?
|
Colonoscopy | 1 | 2014 | 1406 | 0.070 |
Why?
|
Antibodies, Monoclonal | 4 | 2017 | 9249 | 0.060 |
Why?
|
Zinc | 1 | 2010 | 675 | 0.060 |
Why?
|
Disease Management | 1 | 2017 | 2535 | 0.060 |
Why?
|
Pharmaceutical Preparations | 1 | 2014 | 1084 | 0.060 |
Why?
|
Skin Transplantation | 1 | 2011 | 1098 | 0.060 |
Why?
|
Risk Factors | 5 | 2022 | 74840 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2018 | 5783 | 0.060 |
Why?
|
Tendons | 1 | 2010 | 555 | 0.060 |
Why?
|
Receptors, Immunologic | 1 | 2011 | 1415 | 0.060 |
Why?
|
Lysine | 1 | 2010 | 991 | 0.060 |
Why?
|
Hepatitis C | 1 | 2015 | 1597 | 0.060 |
Why?
|
Esophagoscopy | 1 | 2007 | 398 | 0.060 |
Why?
|
Immunotherapy | 1 | 2021 | 4752 | 0.060 |
Why?
|
HCT116 Cells | 2 | 2018 | 399 | 0.060 |
Why?
|
Transplantation, Homologous | 2 | 2011 | 4860 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13648 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2844 | 0.060 |
Why?
|
Optic Disk | 2 | 2006 | 421 | 0.060 |
Why?
|
Biomedical Engineering | 1 | 2006 | 284 | 0.060 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2011 | 790 | 0.060 |
Why?
|
Metabolomics | 1 | 2014 | 1668 | 0.060 |
Why?
|
Computer-Aided Design | 1 | 2006 | 291 | 0.060 |
Why?
|
Microscopy, Electron, Transmission | 2 | 2017 | 684 | 0.060 |
Why?
|
Angioplasty | 1 | 2006 | 352 | 0.060 |
Why?
|
Particle Size | 3 | 2013 | 1631 | 0.050 |
Why?
|
Color | 2 | 2018 | 299 | 0.050 |
Why?
|
Oxygen | 1 | 2015 | 4241 | 0.050 |
Why?
|
Xenopus laevis | 1 | 2007 | 964 | 0.050 |
Why?
|
Cell Proliferation | 5 | 2017 | 10429 | 0.050 |
Why?
|
Monte Carlo Method | 1 | 2008 | 1238 | 0.050 |
Why?
|
Barrett Esophagus | 1 | 2007 | 494 | 0.050 |
Why?
|
Cerebrovascular Circulation | 1 | 2013 | 2674 | 0.050 |
Why?
|
Filtration | 1 | 2003 | 224 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2021 | 11888 | 0.050 |
Why?
|
Cell Membrane | 1 | 2012 | 3634 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2013 | 2900 | 0.050 |
Why?
|
Carcinoma | 1 | 2014 | 2312 | 0.050 |
Why?
|
Liver | 3 | 2012 | 7562 | 0.050 |
Why?
|
Gold | 2 | 2016 | 482 | 0.050 |
Why?
|
RNA, Small Interfering | 3 | 2017 | 3421 | 0.050 |
Why?
|
Time Factors | 5 | 2014 | 40065 | 0.050 |
Why?
|
Transfection | 1 | 2010 | 5743 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 2 | 2015 | 462 | 0.050 |
Why?
|
Calcium | 1 | 2015 | 5767 | 0.050 |
Why?
|
Adolescent | 4 | 2019 | 88835 | 0.050 |
Why?
|
DNA | 2 | 2018 | 7202 | 0.050 |
Why?
|
Heart Rate | 1 | 2013 | 4204 | 0.050 |
Why?
|
Down-Regulation | 3 | 2015 | 2927 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4392 | 0.050 |
Why?
|
Esophagus | 1 | 2007 | 1037 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2022 | 2453 | 0.050 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2015 | 636 | 0.040 |
Why?
|
Signal Transduction | 4 | 2017 | 23601 | 0.040 |
Why?
|
Coronary Vessels | 2 | 2008 | 3096 | 0.040 |
Why?
|
Stem Cells | 1 | 2012 | 3540 | 0.040 |
Why?
|
Graft Survival | 1 | 2010 | 3890 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12240 | 0.040 |
Why?
|
Polymerase Chain Reaction | 3 | 2015 | 6069 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 4913 | 0.040 |
Why?
|
Mice, Hairless | 1 | 2018 | 39 | 0.040 |
Why?
|
Phosphorylation | 3 | 2017 | 8278 | 0.040 |
Why?
|
Gallium | 1 | 2018 | 30 | 0.040 |
Why?
|
Glomerular Filtration Rate | 2 | 2019 | 2233 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2012 | 3797 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2011 | 4209 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 3 | 2015 | 8102 | 0.040 |
Why?
|
Osmolar Concentration | 1 | 2019 | 655 | 0.040 |
Why?
|
Aluminum | 1 | 2018 | 150 | 0.040 |
Why?
|
Muscle, Skeletal | 2 | 2010 | 4958 | 0.040 |
Why?
|
Lipids | 1 | 2008 | 3315 | 0.040 |
Why?
|
Hemagglutination Inhibition Tests | 1 | 2017 | 87 | 0.040 |
Why?
|
Chemokine CX3CL1 | 1 | 2017 | 60 | 0.030 |
Why?
|
DNA Methylation | 1 | 2011 | 4424 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2012 | 4270 | 0.030 |
Why?
|
Republic of Korea | 1 | 2019 | 588 | 0.030 |
Why?
|
Urinalysis | 1 | 2019 | 368 | 0.030 |
Why?
|
Melanoma | 1 | 2015 | 5719 | 0.030 |
Why?
|
Gastrointestinal Tract | 2 | 2015 | 834 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2021 | 65188 | 0.030 |
Why?
|
Vaccines, Inactivated | 1 | 2017 | 185 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2010 | 3111 | 0.030 |
Why?
|
Benzylamines | 1 | 2017 | 251 | 0.030 |
Why?
|
Heterocyclic Compounds | 1 | 2017 | 245 | 0.030 |
Why?
|
Infrared Rays | 1 | 2017 | 246 | 0.030 |
Why?
|
Cell Communication | 1 | 2023 | 1660 | 0.030 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2017 | 163 | 0.030 |
Why?
|
Mass Spectrometry | 2 | 2014 | 2194 | 0.030 |
Why?
|
Mice, Inbred mdx | 1 | 2015 | 90 | 0.030 |
Why?
|
Nanoconjugates | 1 | 2015 | 22 | 0.030 |
Why?
|
Ligation | 1 | 2016 | 444 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2017 | 455 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2017 | 545 | 0.030 |
Why?
|
Cross Reactions | 1 | 2017 | 824 | 0.030 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 2015 | 178 | 0.030 |
Why?
|
Hyperthermia, Induced | 1 | 2018 | 415 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 2014 | 2887 | 0.030 |
Why?
|
Coronary Angiography | 1 | 2006 | 4493 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5891 | 0.030 |
Why?
|
Myostatin | 1 | 2015 | 129 | 0.030 |
Why?
|
Lipolysis | 1 | 2015 | 211 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 612 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2015 | 379 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2019 | 81514 | 0.030 |
Why?
|
Hexosamines | 1 | 2014 | 40 | 0.030 |
Why?
|
Collagen Type I | 1 | 2017 | 615 | 0.030 |
Why?
|
Skin Absorption | 1 | 2014 | 97 | 0.030 |
Why?
|
Kallikreins | 1 | 2015 | 220 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2011 | 10261 | 0.030 |
Why?
|
Myelin Sheath | 1 | 2017 | 652 | 0.030 |
Why?
|
Blotting, Western | 2 | 2012 | 5020 | 0.030 |
Why?
|
Diffusion | 1 | 2015 | 808 | 0.030 |
Why?
|
Molecular Weight | 1 | 2015 | 2163 | 0.030 |
Why?
|
Hypertension | 1 | 2013 | 8626 | 0.030 |
Why?
|
Rats | 3 | 2015 | 23707 | 0.030 |
Why?
|
Fourier Analysis | 1 | 2014 | 434 | 0.030 |
Why?
|
Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 17 | 0.030 |
Why?
|
Microvessels | 1 | 2017 | 591 | 0.030 |
Why?
|
Chitosan | 1 | 2014 | 138 | 0.030 |
Why?
|
Androstenes | 1 | 2014 | 178 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2878 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2016 | 616 | 0.020 |
Why?
|
Dendritic Cells | 2 | 2015 | 2747 | 0.020 |
Why?
|
Diamines | 1 | 2012 | 60 | 0.020 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2012 | 157 | 0.020 |
Why?
|
TNF Receptor-Associated Factor 2 | 1 | 2012 | 56 | 0.020 |
Why?
|
Tensile Strength | 1 | 2013 | 332 | 0.020 |
Why?
|
Regional Blood Flow | 2 | 2006 | 1478 | 0.020 |
Why?
|
Dextran Sulfate | 1 | 2013 | 255 | 0.020 |
Why?
|
Lymph Nodes | 2 | 2015 | 3454 | 0.020 |
Why?
|
Butylhydroxybutylnitrosamine | 1 | 2011 | 2 | 0.020 |
Why?
|
Tin Compounds | 1 | 2011 | 8 | 0.020 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2013 | 164 | 0.020 |
Why?
|
Gene Expression | 2 | 2015 | 7584 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2015 | 2014 | 0.020 |
Why?
|
GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2011 | 34 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2012 | 629 | 0.020 |
Why?
|
Immunization | 1 | 2015 | 1219 | 0.020 |
Why?
|
Intracellular Space | 1 | 2012 | 198 | 0.020 |
Why?
|
Automation | 1 | 2014 | 585 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2012 | 463 | 0.020 |
Why?
|
Aldehydes | 1 | 2012 | 168 | 0.020 |
Why?
|
Receptor, TIE-2 | 1 | 2011 | 183 | 0.020 |
Why?
|
Child | 2 | 2016 | 80564 | 0.020 |
Why?
|
Receptors, Lysosphingolipid | 1 | 2011 | 121 | 0.020 |
Why?
|
Mutation | 1 | 2015 | 30198 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2014 | 1526 | 0.020 |
Why?
|
Genes, myc | 1 | 2011 | 393 | 0.020 |
Why?
|
Monophenol Monooxygenase | 1 | 2010 | 73 | 0.020 |
Why?
|
Caspase 3 | 1 | 2012 | 731 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2012 | 870 | 0.020 |
Why?
|
Men | 1 | 2010 | 65 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2011 | 939 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2012 | 4348 | 0.020 |
Why?
|
Amino Acids | 1 | 2015 | 1709 | 0.020 |
Why?
|
Phylogeny | 1 | 2017 | 2832 | 0.020 |
Why?
|
Cytokines | 2 | 2015 | 7421 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1599 | 0.020 |
Why?
|
Electrodes | 1 | 2011 | 609 | 0.020 |
Why?
|
Body Mass Index | 2 | 2019 | 13039 | 0.020 |
Why?
|
Janus Kinase 2 | 1 | 2012 | 562 | 0.020 |
Why?
|
Chelating Agents | 1 | 2010 | 380 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3608 | 0.020 |
Why?
|
Insulin | 1 | 2023 | 6599 | 0.020 |
Why?
|
Surface Properties | 1 | 2011 | 1151 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2015 | 1789 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4137 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2476 | 0.020 |
Why?
|
Fasting | 1 | 2014 | 1606 | 0.020 |
Why?
|
Ubiquitination | 1 | 2012 | 996 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2010 | 1377 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2010 | 1984 | 0.020 |
Why?
|
Species Specificity | 1 | 2011 | 2406 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2017 | 2010 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1884 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2018 | 3430 | 0.020 |
Why?
|
Analog-Digital Conversion | 1 | 2006 | 23 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2010 | 561 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 2825 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1968 | 0.020 |
Why?
|
Chickens | 1 | 2008 | 842 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 1742 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3807 | 0.020 |
Why?
|
Phagocytosis | 1 | 2011 | 1520 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3596 | 0.020 |
Why?
|
Influenza, Human | 1 | 2017 | 1539 | 0.020 |
Why?
|
Brain Injuries | 1 | 2017 | 2060 | 0.020 |
Why?
|
Wound Healing | 1 | 2017 | 2792 | 0.020 |
Why?
|
Larva | 1 | 2007 | 511 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9296 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2017 | 3211 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2015 | 2464 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2006 | 236 | 0.020 |
Why?
|
Risk Assessment | 2 | 2019 | 24282 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2796 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10603 | 0.020 |
Why?
|
Muscles | 1 | 2010 | 1578 | 0.010 |
Why?
|
Cholesterol | 1 | 2014 | 2898 | 0.010 |
Why?
|
Vaccination | 1 | 2017 | 3426 | 0.010 |
Why?
|
Regression Analysis | 1 | 2014 | 6322 | 0.010 |
Why?
|
Periodicity | 1 | 2005 | 345 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2011 | 1624 | 0.010 |
Why?
|
Glucose | 1 | 2015 | 4335 | 0.010 |
Why?
|
Tumor Burden | 1 | 2010 | 1885 | 0.010 |
Why?
|
NF-kappa B | 1 | 2012 | 2485 | 0.010 |
Why?
|
Nonlinear Dynamics | 1 | 2006 | 490 | 0.010 |
Why?
|
Lymphocytes | 1 | 2011 | 2599 | 0.010 |
Why?
|
HEK293 Cells | 1 | 2012 | 4260 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2010 | 2721 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18380 | 0.010 |
Why?
|
Internet | 1 | 2014 | 3106 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2010 | 1811 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9649 | 0.010 |
Why?
|
Liver Cirrhosis | 1 | 2012 | 1959 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8529 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10070 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8501 | 0.010 |
Why?
|
Cardiovascular System | 1 | 2009 | 841 | 0.010 |
Why?
|
Ethanol | 1 | 2007 | 1323 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2013 | 3081 | 0.010 |
Why?
|
Adenocarcinoma | 2 | 2010 | 6364 | 0.010 |
Why?
|
Killer Cells, Natural | 1 | 2010 | 2210 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12403 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6499 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2012 | 3000 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 4908 | 0.010 |
Why?
|
Lung | 1 | 2017 | 10033 | 0.010 |
Why?
|
Pyridines | 1 | 2010 | 2888 | 0.010 |
Why?
|
Genomics | 1 | 2014 | 5929 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2015 | 11641 | 0.010 |
Why?
|
Kidney | 1 | 2012 | 7066 | 0.010 |
Why?
|
Radiography | 1 | 2007 | 6919 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2010 | 3236 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2007 | 4697 | 0.010 |
Why?
|
Cohort Studies | 1 | 2010 | 41649 | 0.000 |
Why?
|